Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Canadian Cancer Trials Group
University of Washington
H. Lee Moffitt Cancer Center and Research Institute
Duke University
Viron Therapeutics Inc
University Hospital Freiburg
Mateon Therapeutics
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC